AZGP1 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6628a
Background:
AZGP1 stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. It may bind polyunsaturated fatty acids.
Other Names:
Zinc-alpha-2-glycoprotein, Zn-alpha-2-GP, Zn-alpha-2-glycoprotein, AZGP1, ZAG, ZNGP1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6628a was selected from the N-term region of human AZGP1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: AZGP1
Gene ID: 563
Primary Accession: P25311
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
AZGP1 stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. It may bind polyunsaturated fatty acids.
Other Names:
Zinc-alpha-2-glycoprotein, Zn-alpha-2-GP, Zn-alpha-2-glycoprotein, AZGP1, ZAG, ZNGP1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6628a was selected from the N-term region of human AZGP1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: AZGP1
Gene ID: 563
Primary Accession: P25311
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review